Supplementary Table 3.

WGCNA identified 89 risk genes related to abnormal psychomotor behavior characteristics in patients with schizophrenia.

IFI16, ETS1, BTAF1, LFNG, HHEX, ITPR2, MT1X, REL, RELT, NCOA4, SAMSN1, SIAH1, FBXO3, TAPBP, CTSD, GRASP, CXCL8, PTGS2, ACTG1, RNF38, HES1, ADM, PPP1R12A, FOS, SAT1, MAP3K8, FYN, NFE2L2, NRARP, DNAJB1, SNAI1, TBL1XR1, MN1, BCL3, CFL1, GABPB1, LONRF1, PLAU, ADORA3, SSBP3, F13A1, CD83, TRIM11, CITED2, IL1B, DUOX2, AREG, SERPINB2, CXCL2, VEZF1, PTGER3, FUT5, ABHD2, LEF1, TMCC3, HP1BP3, ZNF547, ATP2B1, NFE2, HBEGF, IL1RAP, ZNF331, PFKFB3, KPNA5, MT1E, LYZ, UVSSA, NXPE3, MT2A, PER1, EGR2, RBM5, HOMEZ, EGR3, BACH2, ZNF180, HRH4, EGR1, ATF3, NFAT5, PIN4, LRP1, ELL, ACSL1, EIF5, HNRNPA1, NABP1, CTDSPL2, CIRBP